Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

DIRECTOR DEALINGS: Advanced Oncotherapy Directors Up Interest

8th Jun 2015 08:59

LONDON (Alliance News) - Advanced Oncotherapy PLC Monday said Chief Executive Officer Sanjee Pandya and Chief Financial Officer Nicolas Serandour each bought 220,000 shares at a price of 9 pence per share Friday.

Th company also said that Fairford Capital Ltd, of which Non-Executive Director Michael Bradfield is the sole beneficial owner, purchased 1.5 million shares at 9.81 pence each Wednesday.

Following these transactions, Pandya now holds 590,400 shares representing 0.044% of the issued share capital of the company, Serandour holds 220,000 shares representing 0.016%, and Bradfield has 122 million shares representing 8.941%.

Shares in the proton therapy systems provider were down 1.4% at 9.00p Monday.

By Arvind Bhunjun; [email protected]; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.


Related Shares:

AVO.L
FTSE 100 Latest
Value8,809.74
Change53.53